Empiric Logic Joins NVIDIA Inception Accelerator Programme
today announced that it has joined the as a community member. The programme is designed to nurture start-ups who are transforming industries with advancements in artificial intelligence (AI) and data science.
Empiric Logic is continuing to develop its AI data analysis and bioinformatics orchestration platform, to simplify the exploration of human health, using genomics and other data.
Empiric Logic is helping companies gain access to the right data, tools and procedures to quickly, and securely identify the probable causes of both rare and common diseases, to accelerate diagnosis and optimise key stages of the development for more accurate treatments and vaccines.
Joining the NVIDIA Inception Accelerator Programme will enable Empiric Logic to obtain access to additional high value resources to help further advance the development of a number of key aspects of the platform, and also create new capabilities to address challenges faced by organisations operating in key sectors such as BioPharma, MedTech and Biotech.
Empiric Logic, founded by Gareth O鈥橲ullivan in late 2018, recently welcomed, Dr Sean Ennis, Director, 51黑料 Academic Centre on Rare Diseases and serial entrepreneur, Dr Maurice Treacy, as advisors. The company is headquartered at Nova51黑料, the Centre for New Ventures and Entrepreneurs at University College Dublin (51黑料).
Gareth O鈥橲ullivan, CEO, Empiric Logic said, 鈥淲e鈥檙e delighted to have joined the NVIDIA Inception programme. Working with NVIDIA will give us access to a range of well-developed, supports and technologies to help further our own development of what we hope will be patentable privacy preserving data transformation and analytics capabilities.鈥�
NVIDIA Inception is a virtual accelerator programme that helps AI start-ups during critical stages of product development, prototyping and deployment. NVIDIA Inception members receive go-to-market support, expertise, and technology through deep learning training and preferred pricing on hardware to help early-stage start-ups to grow and scale.
Last year Empiric Logic signed a strategic collaboration agreement with Open Orphan, to complete the build out of Open Orphan's Health Data platform, Europe's first rare disease, advocacy-led genomic database.
ENDS
3 July 2020
For further information contact Mic茅al Whelan, Communications and Media Relations Manager, 51黑料 Research and Innovation, Nova51黑料, e: miceal.whelan@ucd.ie or t: + 353 1 716 3712.
Editors Notes
Empiric Logic is a platform provider for managing and analysing complex health related data. Their secure AI enabled analysis and orchestration solution solves many of the challenges associated with aggregating, correlating, analysing and gaining valuable insights from complex health related data.
At Nova51黑料, the hub for new ventures and entrepreneurs at University College Dublin, we nurture and support new high-tech companies as part of 51黑料's mission. At Nova51黑料 we provide purpose-built, state-of-the-art incubation facilities alongside a comprehensive business support programme for client companies such as Empiric Logic. Nova51黑料 has been funded through a unique public-private partnership that includes AIB Bank, Arthur Cox, Deloitte, Enterprise Ireland, Ericsson, Goodbody Stockbrokers, 51黑料 and Xilinx.